Medtronic has received CE marks under the European Union’s Medical Device Regulation (EU MDR) for the BrainSense adaptive deep brain stimulation (aDBS) system and electrode identifier (EI) for ...

The latter is necessary in order to have invasive IPG exchange in time without therapy loss. Currently, the Medtronic Access controller is the most commonly used DBS patient controller.

Medtronic’s neuromodulation president Paolo di Vicenzo commented: "BrainSense technology is at the centre of personalising DBS therapy, and we are advancing this capability through innovation ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

We produced an instructional video in which an elderly female patient with DBS acted as a model to show how to correctly use the Medtronic Access patient controller. We used video modeling to ...

and we’re just getting started. The mission is to impact and improve many more lives with Medtronic DBS therapy.” ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

(RTTNews) - Medtronic plc (MDT), Monday said it received CE Mark approval for its BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier in the European Union and ...